Rad23B Activators
The chemical class of Rad23B activators comprises a diverse array of compounds that can modulate Rad23B expression and function through various signaling pathways and cellular processes. One notable group includes inhibitors of NF-κB activation, such as BAY 11-7082. By suppressing NF-κB signaling, BAY 11-7082 indirectly influences Rad23B activity, as NF-κB is intricately connected with the regulation of genes involved in various cellular processes, including Rad23B. Histone acetyltransferase (HAT) inhibitors, exemplified by C646, provide another avenue for Rad23B modulation. C646's selective inhibition of p300, a HAT, can indirectly impact Rad23B by altering chromatin dynamics and gene expression patterns associated with Rad23B regulation. This highlights the role of epigenetic regulation in controlling Rad23B activity within the cellular context. Compounds like ICG-001 and FH535, acting as Wnt/β-catenin pathway inhibitors, demonstrate another facet of Rad23B modulation. These compounds indirectly influence Rad23B by disrupting downstream events related to Wnt signaling, showcasing the interconnectedness of cellular processes and the potential impact on Rad23B expression and function.
The BET inhibitor JQ1 and Tankyrase inhibitor PRT4165 showcase the influence of chromatin dynamics and Wnt/β-catenin signaling on Rad23B regulation. JQ1's impact on BET proteins and PRT4165's inhibition of Tankyrase highlight the role of these factors in modulating Rad23B through chromatin modifications and Wnt pathway regulation. BEZ235, a dual PI3K/mTOR inhibitor, and KG-501, a TGF-β/Smad signaling inhibitor, exemplify compounds that indirectly modulate Rad23B by affecting key signaling pathways. NVP-BEZ235 disrupts the PI3K/AKT/mTOR pathway, while KG-501 targets TGF-β/Smad signaling, showcasing the impact of these pathways on Rad23B expression and function. In summary, Rad23B activators represent a group of compounds that can influence Rad23B expression and function through diverse molecular mechanisms, including the modulation of signaling pathways, chromatin dynamics, and epigenetic regulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
ATRA is a derivative of vitamin A and acts as an agonist for retinoic acid receptors (RARs). Through RAR activation, ATRA influences transcriptional regulation and can potentially modulate Rad23B expression, indirectly affecting cellular processes associated with Rad23B. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is an inhibitor of NF-κB activation, and its suppression of NF-κB signaling can indirectly influence Rad23B activity. NF-κB is involved in the regulation of various genes, and BAY 11-7082's impact on this pathway can potentially modulate Rad23B expression and function. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a selective inhibitor of histone acetyltransferase (HAT) p300. By modulating histone acetylation, C646 can indirectly influence Rad23B by altering chromatin dynamics and gene expression patterns associated with Rad23B regulation. | ||||||
β-Catenin/Tcf Inhibitor, FH535 | 108409-83-2 | sc-221398 sc-221398A | 10 mg 50 mg | $182.00 $374.00 | 7 | |
FH535 is a dual inhibitor of Wnt/β-catenin and peroxisome proliferator-activated receptor (PPAR). Its influence on the Wnt pathway may indirectly affect Rad23B, as Wnt signaling is interconnected with various cellular processes, and modulation of this pathway can impact Rad23B expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a bromodomain and extraterminal domain (BET) inhibitor, affecting bromodomain-containing proteins. Its influence on BET proteins can indirectly affect Rad23B by modulating chromatin dynamics and gene expression patterns associated with Rad23B regulation. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $211.00 | 8 | |
BEZ235 is a dual PI3K/mTOR inhibitor, affecting the PI3K/AKT/mTOR signaling pathway. Its modulation of this pathway can indirectly influence Rad23B by disrupting downstream events and altering cellular responses associated with the PI3K/AKT/mTOR pathway. | ||||||
PRT4165 | 31083-55-3 | sc-507487 | 10 mg | $134.00 | ||
PRT4165 is a selective inhibitor of Tankyrase, impacting the Wnt/β-catenin pathway. Its inhibition of Tankyrase can indirectly modulate Rad23B by influencing downstream events and altering cellular responses associated with Wnt signaling and Tankyrase-dependent regulation. | ||||||
PTP CD45 Inhibitor | 345630-40-2 | sc-222223A sc-222223 | 1 mg 5 mg | $104.00 $306.00 | 1 | |
SF1670 (PTP CD45 Inhibitor) is an inhibitor of the dual-specificity phosphatase CDC25B. Its influence on CDC25B can indirectly affect Rad23B by modulating cellular responses related to CDC25B-dependent signaling cascades, showcasing the interconnectedness of phosphatase activity and Rad23B regulation. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV-939 is a tankyrase inhibitor that impacts the Wnt/β-catenin pathway. Its modulation of Tankyrase can indirectly influence Rad23B by disrupting downstream events and altering cellular responses associated with Wnt signaling and Tankyrase-dependent regulation. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
Z-VAD-FMK is a pan-caspase inhibitor, affecting apoptotic pathways. Its inhibition of caspases can indirectly influence Rad23B by altering cellular responses related to caspase-dependent signaling cascades, showcasing the interplay between apoptosis and Rad23B regulation. | ||||||